Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06572397 · ClinicalTrials.gov registry record · Phase 1
Open-Label Study of Safety of H1337 in Healthy Volunteers
A Phase 1 study, sponsored by D. Western Therapeutics Institute.
- Completed
- Registry status
- Phase 1
- Development phase
- 17
- Enrollment target
NCT06572397 is a Phase 1 study that has completed, run by D. Western Therapeutics Institute. The registered enrollment target is 17 participants.
The verdict
NCT06572397, a Phase 1 study, has completed, sponsored by D. Western Therapeutics Institute.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 17 participants
- Enrollment target
Study Summary
The trial will evaluate the safety of one dose regimen of H-1337 \[1% twice daily (b.i.d.)\] in both eyes in healthy volunteers.
Interventions
- DRUG H-1337 1.0%
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2024-09-16 |
| Est. Completion | 2024-10-14 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06572397
The ClinicalTrials.gov registry entry for NCT06572397 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is D. Western Therapeutics Institute, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which H-1337 1.0% is the first listed.
NCT06572397 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06572397 about?
NCT06572397 is a clinical study titled "Open-Label Study of Safety of H1337 in Healthy Volunteers". The trial will evaluate the safety of one dose regimen of H-1337 \[1% twice daily (b.i.d.)\] in both eyes in healthy volunteers.
What is the current status of trial NCT06572397?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 17 participants. The study started on 2024-09-16. Estimated completion is 2024-10-14.
What interventions are being tested in trial NCT06572397?
The interventions under investigation include: H-1337 1.0% (DRUG).
Who is sponsoring clinical trial NCT06572397?
This trial is sponsored by D. Western Therapeutics Institute, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.